# Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş.

Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş. is Turkey's largest pharmaceutical company, founded in 1912 in Küçükmustafapaşa, Istanbul by pharmacist Abdi Nadir İbrahim Bey and now run by the third generation of the founding family under chairman Nezih Barut. The company has led Turkey's pharmaceutical industry since 2002 and develops the sector's largest portfolio: close to 250 brands and more than 500 products spanning general treatments, central nervous system, specialty care, respiratory and consumer health. Manufacturing is centred on the 174,600 m² Esenyurt Production Complex near Istanbul (opened 2000; ~700 million boxes/year capacity; GMP/GLP; ISO 9001, ISO 14001 and ISO 45001 certified and audited by European health authorities) and the AbdiBio biotechnology plant (13,500 m², opened 2018), backed by Turkey's first accredited pharmaceutical R&D centre. Abdi İbrahim operates in 17 countries outside Turkey and exports to more than 70 countries, and runs a 50/50 joint venture, Abdi İbrahim Otsuka, with Japan's Otsuka Pharmaceutical.

## Overview

- **Type:** شركة مصنِّعة
- **Country:** تركيا
- **Headquarters:** Abdi İbrahim Tower, Reşitpaşa, Sarıyer, İstanbul, Türkiye
- **Founded:** 1912
- **Products listed:** 246
- **Certifications:** ISO 9001, ISO 14001, ISO 45001, GMP, GLP

## Key strengths

- Turkey's largest pharmaceutical portfolio: ~250 brands and 500+ products developed largely in-house.
- Massive GMP/GLP manufacturing footprint: 174,600 m² Esenyurt complex, ~700 million boxes/year, audited by European health authorities.
- AbdiBio biotechnology plant (13,500 m²): one of Turkey's largest biotech drug-manufacturing facilities.
- Turkey's first accredited pharmaceutical R&D centre with inhalation-technology and nanotechnology formulation capability.
- International reach: operations in 17 countries and exports to 70+ countries; 50/50 joint venture with Otsuka Pharmaceutical.

## Product lines

- **Abdi İbrahim Otsuka**: Innovative medicines co-marketed through Abdi İbrahim Otsuka, the 50/50 joint venture (established 2012) with Japan's Otsuka Pharmaceutical.
- **Genel Tedaviler** (62 products): General-treatment prescription medicines across dermatology, pain, anticoagulation, gastroenterology and other broad therapeutic areas: Abdi İbrahim's core primary-care portfolio.
- **Merkezi Sinir Sistemi** (30 products): Central nervous system medicines for psychiatric disorders and neurological diseases: antipsychotics, antidepressants, antiepileptics and Parkinson's therapies.
- **Özel Tedaviler** (51 products): Specialty-care and hospital medicines including oncology, biotechnology-derived products, and complex chronic-disease therapies.
- **Solunum** (17 products): Respiratory medicines including inhalation therapies, developed with Abdi İbrahim's dedicated inhalation-technology R&D capability.
- **Tanıtılmayan Ürünler** (44 products): Non-promoted marketed products: established medicines in the portfolio that are supplied but not actively detailed to physicians.
- **Tüketici Sağlığı** (35 products): Consumer-health and OTC portfolio: vitamins, minerals and supplements, probiotics, melatonin, baby health, skin care, sexual health, and cold & cough products.

## Capabilities

- OEM
- Contract manufacturing
- Actively seeking distributors

## Target customers

- Hospitals
- Pharmacies
- Physicians and healthcare professionals
- Patients
- Export distributors / licensors

## Facilities

- production, Esenyurt, İstanbul, Türkiye
- production, Esenyurt, İstanbul, Türkiye (AbdiBio biotechnology plant)
- rd, İstanbul, Türkiye (R&D Centre)
- production, Kazakhstan
- production, Algeria
- warehouse, Teknojistik (techno-logistics) Centre, İstanbul, Türkiye

## Distribution reach

TR/JP, سويسرا, تركيا

> Contact Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş. via their [profile page](https://dev.mytradeloop.com/ar/companies/abdi-ibrahim-ilac-sanayi-ve-ticaret-a-s-9667).

---

*Source: [mytradeloop](https://dev.mytradeloop.com/ar/companies/abdi-ibrahim-ilac-sanayi-ve-ticaret-a-s-9667). This is the machine-readable (markdown) representation of the page at https://dev.mytradeloop.com/ar/companies/abdi-ibrahim-ilac-sanayi-ve-ticaret-a-s-9667.*